Overview
- 110 inspections across 107 sites are on record.
- 353 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-04-13.
At a glance
Inspections
110
Sites
107
Observations
353
Career since
Nov 2014
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Acella Pharmaceuticals, LLC | 13 Apr 2026 | Human Drugs | |
| Alora Pharmaceuticals | 13 Apr 2026 | Human Drugs | On file |
| Aurobindo Pharma Limited | 10 Feb 2026 | Human Drugs | On file |
| Centrient Pharmaceuticals India Private Limited | 27 Jan 2026 | Human Drugs | On file |
| Lupin Limited | 21 Nov 2025 | Human Drugs | On file |
Sites inspected
Acella Pharmaceuticals, LLCAlpharetta, United States1 insp.
Alora PharmaceuticalsAlpharetta, United States1 insp.
Aurobindo Pharma LimitedJedcherla Mandal, Mahabubnagar, India1 insp.
Centrient Pharmaceuticals India Private LimitedNawashahr, India1 insp.
Lupin LimitedVerna, India1 insp.
Co-investigators
Investigators who share inspections with this person.
Arsen Karapetyan5 shared
Justin A Boyd4 shared
Tamil Arasu4 shared
Jose E Melendez4 shared
Massoud Motamed4 shared
Timothy H Vo3 shared
Saleem A Akhtar3 shared
Liming Zhang3 shared
Christopher S Keating3 shared
Lillie D Witcher3 shared
Full investigator report
Get the verbatim findings behind Pratik S Upadhyay's 353 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site